Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy. - Wikidata - awgldk - TriplyDB

Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy.

Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy.

http://www.wikidata.org/entity/Q44358822

about

Ferulsinaic Acid Modulates SOD, GSH, and Antioxidant Enzymes in Diabetic Kidney Guizhi-Fuling-Wan, a Traditional Chinese Herbal Medicine, Ameliorates Memory Deficits and Neuronal Apoptosis in the Streptozotocin-Induced Hyperglycemic Rodents via the Decrease of Bax/Bcl2 Ratio and Caspase-3 Expression Oat Attenuation of Hyperglycemia-Induced Retinal Oxidative Stress and NF-κB Activation in Streptozotocin-Induced Diabetic Rats The renal effects of blood glucose-lowering plant-derived extracts in diabetes mellitus--an overview.Traditional Japanese herbal (kampo) medicines and treatment of ocular diseases: a review.Chinese medicine for treating diabetic nephropathy.What has been overlooked on study of Chinese materia medica in the West?Evidence-based efficacy of Kampo formulas in a model of non alcoholic fatty liver.Vulnerability of Gastric Mucosa in Diabetic Rats, Its Pathogenesis and Amelioration by Cuminum cyminum.Neuroprotection of Gueichih-Fuling-Wan on cerebral ischemia/ reperfusion injury in streptozotocin-induced hyperglycemic rats via the inhibition of the cellular apoptosis pathway and neuroinflammation.Long-term treatment with Hachimi-jio-gan attenuates kidney damage in spontaneously diabetic WBN/Kob rats.The genotoxicity of an aqueous extract of Gyejibokryeong-hwan.Ferulsinaic acid attenuation of diabetic nephropathy.

P2860

Q36237698-2AB2ADC6-4038-4F29-A17A-7398C1238C34 Q36470919-6C0F01CA-88FC-4959-B895-74413C6B854E Q36566092-A1474B8F-F53B-4F57-9527-50AEF4AC276D Q37683784-363D0DEF-6AD2-4543-AC1B-DECFC44BB4E7 Q38038685-71ED2C2E-CD5C-4FB3-8E31-0E3ECDC6649C Q38093117-C9DBA231-50F7-440E-B4DF-4737E9AB67AE Q38544110-4D372411-B948-459C-8127-7AD3583A8042 Q40120793-314F4BEF-C71B-40E5-9B5E-C5F1C373B963 Q40919784-3FFF5AF6-AE91-4617-8B92-1843AD670DA9 Q42182162-0B525185-87E7-4EA8-BBEA-DBD5A3084874 Q46654427-D8AAD566-CFD9-49B9-BC5E-072702F9D3F6 Q49189123-18816DF7-34A5-4D0C-9834-1416CF642114 Q51348340-9A06590F-39CD-40C5-B412-137ADDEE0277

P2860

Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy.

http://www.wikidata.org/entity/Q44358822

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh-hant

name

Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy.

@en

Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy.

@nl

type

label

Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy.

@en

Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy.

@nl

prefLabel

Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy.

@en

Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy.

@nl

P1433

Q44358822-139188D3-D49E-45A4-A3AC-9176CCCC2235

P1476

Q44358822-D1B59B83-9A04-4747-AEF5-B0EE124FCDEF

P2093

Q44358822-305E9DA8-1F6C-417B-8E55-D2CF68C9BDA4

Q44358822-41B68BDA-CD3C-463D-82F2-1EBCACCF43D6

Q44358822-9E90BBA7-D7F8-4C1C-92A8-0DAB230205B4

Q44358822-D83DBB17-D21A-45E7-A797-1F0FC3FDB840

P2860

Q44358822-04D46339-2711-43A6-B20F-E03442818016

Q44358822-0EF9020A-2165-4B98-B208-3C2098FA5D39

Q44358822-1E26D612-1981-416C-B706-80D7678BEAD4

Q44358822-2817D6B8-EA4E-4420-A563-269F8117E827

Q44358822-2B0D1DA9-0201-4627-AA6E-88946A3FB923

Q44358822-2C772A18-C4EC-4F4B-97CE-53BBBA7628AA

Q44358822-604E58F6-4380-4EFA-B747-3422D969D8CE

Q44358822-63333B38-2A2F-4954-ABB9-C20AD4FEDDDC

Q44358822-773AE691-3047-4054-A94C-96EE4CCCE3DE

Q44358822-85915604-1A97-406B-A85A-0E77F4646835

P304

Q44358822-85E41587-0A86-4A0C-8F75-1B779587E491

P31

Q44358822-D367A887-D6FD-45DD-8B9C-EEFBFCA4E234

P356

Q44358822-63562404-DDB7-492F-BFFB-567ADBE6348F

P433

Q44358822-C5A78E58-9E04-4E25-89C5-A6F258AAFD74

P478

Q44358822-89724C66-22FB-46F9-B5B5-869DF7E27A77

P577

Q44358822-DA89D16A-21F0-4BBB-A1D4-A7B4F3655CD0

P698

Q44358822-428EDFC0-D210-4F55-B5AC-7ECB2A1B40D8

P356

P1433

Journal of Pharmacy and Pharmacology

P1476

Therapeutic usefulness of Keishi-bukuryo-gan for diabetic nephropathy.

@en

P2093

Katsutoshi Terasawa

http://www.w3.org/2001/XMLSchema#string

Kazuo Nakanishi

http://www.w3.org/2001/XMLSchema#string

Takako Nakagawa

http://www.w3.org/2001/XMLSchema#string

Takako Yokozawa

http://www.w3.org/2001/XMLSchema#string

P2860

Effects of thyroid hormone on the sorbitol pathway in streptozotocin-induced diabetic rats

Pathogenesis of diabetic nephropathy: the role of oxidative stress and protein kinase C.

Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications.

Free radical generation by early glycation products: a mechanism for accelerated atherogenesis in diabetes.

Oxidative stress and diabetic vascular complications.

Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats

Administration of an aldose reductase inhibitor induces a decrease of collagen fluorescence in diabetic rats.

Diabetes-induced glomerular dysfunction: links to a more reduced cytosolic ratio of NADH/NAD+.

Lipid peroxide level in plasma of diabetic patients.

Oxidative alterations in the experimental glycation model of diabetes mellitus are due to protein-glucose adduct oxidation. Some fundamental differences in proposed mechanisms of glucose oxidation and oxidant production.

P304

219-227

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1211/002235702450

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

55

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

12631415

http://www.w3.org/2001/XMLSchema#string